Resveratrol-loaded nanocapsules inhibit murine melanoma tumor growth

Colloids and Surfaces B: Biointerfaces

Volumn 144, Issue , 2016, Pages 65-72

  Carletto, Bruna ^a   Berton, Juliana ^a   Ferreira, Tamara Nascimento ^a   Dalmolin, Luciana Facco ^a   Paludo, Katia Sabrina ^a   Mainardes, Rubiana Mara ^b   Farago, Paulo Vitor ^a   Favero, Giovani Marino ^a  

^a Ponta Grossa State University   (Brazil)

^b Department of Agronomy   (Brazil)

Author keywords

B16F10 cell line; Nanoparticles; PCL; Phytoalexin; Polymeric drug carrier

Indexed keywords

CELL CULTURE; CONTROLLED DRUG DELIVERY; DERMATOLOGY; ENCAPSULATION; MAMMALS; NANOCAPSULES; NANOPARTICLES; ONCOLOGY; TARGETED DRUG DELIVERY; TUMORS;

ANTI-TUMOR ACTIVITIES; CELL LINES; ENCAPSULATION EFFICIENCY; NANO-ENCAPSULATION; NEGATIVE CHARGE; PHYTOALEXIN; POLYMERIC DRUG CARRIERS; PULMONARY HEMORRHAGE;

RESVERATROL;

NANOCAPSULE; RESVERATROL; STILBENE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL INFILTRATION; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFICACY; DRUG FORMULATION; DRUG RESPONSE; ENCAPSULATION; GROWTH INHIBITION; MELANOMA; MELANOMA CELL; MOUSE; NANOENCAPSULATION; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; TREATMENT OUTCOME; TUMOR GROWTH; TUMOR VOLUME; ZETA POTENTIAL; ANIMAL; C57BL MOUSE; CELL PROLIFERATION; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; EXPERIMENTAL MELANOMA; PATHOLOGY; TUMOR CELL LINE; ULTRASTRUCTURE; X RAY DIFFRACTION;

ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; MELANOMA, EXPERIMENTAL; MICE, INBRED C57BL; NANOCAPSULES; STILBENES; TUMOR BURDEN; X-RAY DIFFRACTION;

EID: 84962646260     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2016.04.001     Document Type: Article

References (57)

1. R. Siegel, D. Naishadhamand, A. Jemal, Cancer J. Clin, 63 (2013) 11.
2. Soengas M.S., Lowe S.W. Apoptosis and melanoma chemoresistance. Oncogene 2003, 22:3138.
3. Gray-Schopfer V., Wellbrock C., Marais R. Melanoma biology and new targeted therapy. Nature 2007, 445:851.
4. Olszanski A.J. Current and future roles of targeted therapy and immunotherapy in advanced melanoma. J. Manage. Care Spec. Pharm. 2014, 20:346.
5. Ascierto P.A., Atkins M., Bifulco C., Botti G., et al. Future perspectives in melanoma research: meeting report from the Melanoma Bridge: napoli December 3rd-6th 2014. J. Transl. Med. 2015, 13:374.
6. Signorelli P., Ghidoni R. Resveratrol as an anticancer nutrient: molecular basis, open questions and promises. J. Nutrit. Biochem. 2005, 16:449.
7. Udenigwe C.C., Ramprasath V.R., Aluko R.E., Jones P.J.H. Potential of Resveratrol in anticâncer and anti-inflamatory therapy. Nut. Rev. 2008, 66:445.
8. Baliga M.S., Katiyar S.K. Chemoprevention of photocarcinogenesis by selected dietary botanicals. Photochem. Photobiol. Sci. 2006, 5:243.
9. Nakata R., Takahashi S., Inoue H. Recent advances in the study on resveratrol. Biol. Pharm. Bull. 2012, 35:273.
10. Goswami S.K., Das D.K. Resveratrol and chemoprevention. Cancer Lett. 2009, 284:1.
11. Gülçin I. Antioxidant properties of resveratrol: a structure-activity insight. Innovative Food Sci. Emerg. Technol. 2010, 11:210.
12. Dudley J., Das S., Mukherjee S., Das D.K. Resveratrol, a unique phytoalexin present in red wine, delivers either survival signal or death signal to the ischemic myocardium depending on dose. J. Nut. Biochem. 2009, 20:443.
13. Docherty J.J., Fu M.M., Hah J.M., Sweet T.J., Faith S.A., Booth T. Effect of resveratrol on herpes simplex virus vaginal infection in the mouse. Antiviral Res. 2005, 67:155.
14. Anekonda T.S. Resveratrol-A boon for treating Alzheimer's disease?. Brain Res. Rev. 2006, 52:316.
15. Wu Z., Liu B., Liu C.E.J., Zhang Q., Liu J., Chen N., Chen R., Zhu R. Resveratrol inhibits the proliferation of human melanoma cells by inducing G1/S cell cycle arrest and apoptosis. Mol. Med. Rep. 2015, 11:400.
16. Habibie H., Yokoyama S., Abdelhamed S., Awale S., Sakurai H., Hayakawa Y., Saiki I. Survivin suppression through STAT3/β-catenin is essential for resveratrol-induced melanoma apoptosis. Int. J. Oncol. 2014, 45:895.
17. Kim M.Y. Nitric oxide triggers apoptosis in A375 human melanoma cells treated with capsaicin and resveratrol. Mol. Med. Rep. 2012, 5:585.
18. Chen Y.J., Chen Y.Y., Lin Y.F., Hu H.Y., Liao H.F. Resveratrol inhibits alpha-melanocyte-stimulating hormone signaling, viability, and invasiveness in melanoma cells. Evid. Based Complement. Alternat. Med. 2013, 2013:632121.
19. Neves A.R., Lúcio M., Lima J.L.C., Reis S. Resveratrol in medicinal chemistry: a critical review of its pharmacokinetics, drug-delivery, and membrane interactions. Curr. Med. Chem. 2012, 19:1663.
20. Boocock D.J., Faust G.E.S., Patel K.R., Schinas A.M., Brown V.A., Ducharme M.P., Booth T.D., Crowell J.A., Perloff M., Gescher A.J., Steward W.P., Brenner D.E. Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent. Cancer Epidemiol. Biomarkers Prev. 2007, 16:1246.
21. Baur J.A., Sinclair D.A. Therapeutic potential of resveratrol: the in vivo evidence. Nat. Rev. Drug Discov. 2006, 5:493.
22. Walle T., Hsieh F., Delegge M.H., Oatis J.E., Walle U.K. High absorption but very low bioavailability of oral resveratrol in humans. Drug Metabol. Dispos. 2004, 32:1377.
23. Pangeni R., Sahni J.K., Ali J., Sharma S., Baboota S. Resveratrol: review on therapeutic potential and recent advances in drug delivery. Expert. Opin. Drug Deliv. 2014, 11:1285.
24. Kondratyuk T.P., Park E.J., Marler L.E., et al. Resveratrol derivatives as promising chemopreventive agents with improved potency and selectivity. Mol. Nutr. Food Res. 2011, 55:1249.
25. Mendes J.B.E., Riekes M.K., Oliveira V.M., Michel M.D., Stulzer H.K., Khalil N.M., Zawadzki S.F., Mainardes R.M., Farago P.V. PHBV/PCL microparticles for controlled release of resveratrol: physicochemical characterization, antioxidant potential, and effect on hemolysis of human erythrocytes. Sci. World J. 2012, 2012:1.
26. Lindner G.R., Khalil N.M., Mainardes R.M. Resveratrol-loaded polymeric nanoparticles: validation of an HPLC-pDA method to determine the drug entrapment and evaluation of its antioxidant activity. Sci. World J. 2013, 2013:506083.
27. Lindner G.R., Santos D.B., Colle D., Moreira E.L.G., Prediger R.D., Farina M., Khalil N.M., Mainardes R.M. Improved neuroprotective effects of resveratrol-loaded polysorbate 80-coated poly(lactide) nanoparticles in MPTP-induced Parkinsonism. Nanomedicine 2015, 10:1127.
28. Parveen S., Misra R., Sahoo S.K. Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging. Nanomedicine 2012, 8:147.
29. Khalil N.M., do Nascimento T.C.F., Casa D.M., f.Dalmolin L., de Mattos A.C., Hoss I., Romano M.A., Mainardes R.M. Pharmacokinetics of curcumin-loaded PLGA and PLGA-pEG blend nanoparticles after oral administration in rats. Colloids Surf. B 2013, 101:353.
30. de Mattos A.C., Altmeyer C., Tominaga T.T., Khalil N.M., Mainardes R.M. Polymeric nanoparticles for oral delivery of 5-fluorouracil: formulation optimization, cytotoxicity assay and pre-clinical pharmacokinetics study. Eur. J. Pharm. Sci 2016, 84:83.
31. Feng S.S. Nanoparticles of biodegradable polymers for new-concept chemotherapy. Expert Rev. Med. Devices 2004, 1:115.
32. Brigger I., Dubernet C., Couvreur P. Nanoparticles in cancer therapy and diagnosis. Adv. Drug Deliv. Rev 2012, 64:24.
33. Figueiró F., Bernardi A., Frozza R.I., Terroso T., Zanotto-Filho A., Jandrey E.H., Moreira J.C., Salbego C.G., Edelweiss M.I., Pohlmann A.R., Guterres S.S., Battastini A.M. Resveratrol-loaded lipid-core nanocapsules treatment reduces in vitro and in vivo glioma growth. J. Biomed. Nanotechnol. 2013, 3:516.
34. Karthikeyana S., Prasada N.R., Ganamaniband A., Balamurugana E. Anticancer activity of resveratrol-loaded gelatin nanoparticles on NCI-h460 non-small cell lung cancer cells. Biomed. Prev. Nutrit. 2013, 3:64.
35. Sanna V., Siddiqui I.A., Sechiand M., Mukhtar H. Resveratrol-loaded nanoparticles based on poly(epsilon-caprolactone) and poly(d:l-lactic-co-glycolic acid)-poly(ethylene glycol) blend for prostate cancer treatment. Mol. Pharm. 2013, 10:3871.
36. Fessi H., Puisieux F., Devissaguet J., Ammoury N., Benita S. Nanocapsule formation by interfacial polymer deposition following solvent displacement. Int. J. Pharm 1989, 55:R1.
37. Altmeyer C., Karam T.K., Khalil N.M., Mainardes R.M. Tamoxifen-loaded poly(l-lactide) nanoparticles: Development, characterization and in vitro evaluation of cytotoxicity. Mater. Sci. Eng. C Mater. Biol. Appl. 2016, 60:135.
38. Favero G.M., Otuki M.F., Oliveira K.A., Bohatch M.S., Borelli P., Barros F.E., Maria D.A., Fernandes D., Bydlowski S.P. Simvastatin impairs murine melanoma growth. Lipids Health Dis. 2010, 9:1.
39. Jang M., Cai L., Udeani G.O., Slowing K.V., Thomas C.F., Beecher C.W.W., Fong H.H.S., Farnsworth N.R., Kinghorn A.D., Mehta R.G., Moon R.C., Pezzuto J.M. Cancer Chemopreventive activity of resveratrol, a natural product derived from grapes. Life Sci. 1997, 275:218.
40. Aziz M.H., Kumar R., Ahmad N. Cancer chemopre-vention by resveratrol: in vitro and in vivo studies and the underlying mechanisms. Int. J. Oncol. 2003, 23:17.
41. Kundu J.K., Surh Y.J. Cancer chemopreventive and therapeutic potential of resveratrol: mechanistic perspectives. Cancer Lett. 2008, 269:243.
42. Walle T., Hsieh F., Delegge M.K., Oatis J.E., Walle W. High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab. Dispos. 2004, 32:1377.
43. Sun L., Wu Q., Peng F., Liu L., Gong C. Strategies of polymeric nanoparticles for enhanced internalization in cancer therapy. Colloids Surf. B 2016, 10.1016/j.colsurfb.2015.07.013.
44. Hobbs S.B., Monsky W.L., Yuan F., Roberts W.G., Griffith L., Torchilin V.P., Jain R.K. Regulation of transport pathways in tumor vessels: role of tumor type and micro- environment. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:4607.
45. Jain R.K., Stylianopoulos T. Delivering nanomedicine to solid tumors. Nat. Rev. Clin. Oncol. 2010, 7:653.
46. Avadi M.R., Sadeghi A.M.M., Mohammadpour N., Abedin S., Atyabi F., Dinarvand R., Rafiee-Tehrani M. Preparation and characterization of insulin nanoparticles using chitosan and arabic gum with ionic gelation method. Nanomedicine 2010, 6:58.
47. Panyam J., Williams D., Dash A., Leslie-Pelecky D., Labhasetwar V. Solid-state solubility influences encapsulation and release of hydrophobic drugs from PLGA/PLA nanoparticles. J. Pharm. Sci. 2004, 93:1804.
48. Jose S., Anju S.S., Cinu T.A., Aleykutty N.A., Thomas S., Souto E.B. In vivo pharmacokinetics and biodistribution of resveratrol-loaded solid lipid nanoparticles for brain delivery. Int. J. Pharm. 2014, 474:6.
49. Jung K.H., Lee J.H., Park J.W., Quach C.H., Moon S.H., Cho Y.S., Lee K.H. Resveratrol-loaded polymeric nanoparticles suppress glucose metabolism and tumorgrowth in vitro and in vivo. Int. J. Pharm. 2014, 478:251.
50. Guo L., Peng Y., Yao J., Sui K., Gu A., Wang J. Anticancer activity and molecular mechanism of resveratrol-bovine serum albumin nanoparticles on subcutaneously implanted human primary ovarian carcinoma cell in nude mice. Cancer Biother. Radiopharm. 2010, 25:471.
51. Abedalwafa M., Wang F., Wang L., Li C. Biodegradable poly-epsilon-caprolactone (PCL) for tissue engineering applications: a review. Rev. Adv. Mater. Sci. 2013, 34:123.
52. Fang Y.M.D., Bradley M.J., Cook K.M., Herrick E.J., Nicholl M.B. A potential role for resveratrol as a radiation sensitizer for melanoma treatment. J. Surg. Res. 2013, 183:645.
53. Bareford L.M., Swaan P.W. Endocytic mechanisms for targeted drug delivery. Adv. Drug Deliv. Rev. 2007, 59:748.
54. Williamson G., Manach C. Bioavailability and bioefficacy of polyphenols in humans. II Review of 93 intervention studies. Am. J. Clin. Nut. 2005.
55. Osmond G.W., Augustine C.K., Zipfel P.A., Padussis J., Tyler D.S. Enhancing melanoma treatment with resveratrol. J. Surg. Res. 2012, 172:109.
56. Bertrand N., Wu J., Xu X., Kamaly N., Farokhzad O.C. Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology. Adv. Drug Deliv. Rev. 2014, 66:2.
57. Li J., Wang Y., Liang R., An X., Wang K., Shen G., Tu Y., Zhu J., Tao J. Recent advances in targeted nanoparticles drug delivery to melanoma. Nanomedicine 2015, 11:769.